Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Endovascular closure of ascending aortic pseudoaneurysm with a type II Amplatzer vascular plug

De Boo DW, Mott N, Kavnoudias H, Walton A, Lyon SM

(2014), Vasc Endovasc Surg, 48(4), 329-32

Nutcracker syndrome

Jolley I

(2014), Radiography, 20(3), 286-7

Local diagnostic reference levels for angiographic and fluoroscopic procedures: Australian practice

Erskine BJ, Brady Z, Marshall EM

(2014), Australas Phys Eng Sci Med, 37(1), 75-82

Laboratory detection of 'Clostridium difficile'

Dennison A

(2014), Aust J Med Sci, 35(4), 110-25

Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study

Lim CJ, Cheng AC, Kennon J, Spelman D, Hale D, Melican G, Sidjabat HE, Paterson DL, Kong DC, Peleg AY

(2014), J Antimicrob Chemother, 69(7), 1972-80

Rickettsial infections in Southeast Asia: implications for local populace and febrile returned travelers

Aung AK, Spelman DW, Murray RJ, Graves S

(2014), Am J Trop Med Hyg, 91(3), 451-60

Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia

Cheah AL, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC

(2014), BMC Infect Dis, 14, 353

A case of gonococcal necrotising fasciitis

Kanhutu KN, Spelman DD, Weymouth MD

(2014), Sex Health, 11(3), 280-2

Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients

Govindaraj C, Tan P, Walker P, Wei A, Spencer A, Plebanski M

(2014), Clin Cancer Res, 20(3), 724-35

Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients

Govindaraj C, Madondo M, Kong YY, Tan P, Wei A, Plebanski M

(2014), Am J Hematol, 89(8), 795-802

Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care

Iland HJ, Wei A, Seymour JF

(2014), Best Pract Res Clin Haematol, 27(1), 39-52

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

Cummins KD, Jane SM, Ninkovic S, Bazargan A, Filshie R, Sutrave G, Hertzberg M, Scott A, Lane S, Yannakou CK, Ritchie D, D'Rozario J, Black J, Bavishi K, Wei A

(2014), Blood Cancer J, 4, e237

Inter-laboratory discordance of beta-2 microglobulin results: impact on the validity of the international staging system for multiple myeloma

Fedele PL, Choy KW, Doery JC, Grigoriadis G, Shortt J, Lu ZX

(2014), Br J Haematol, 166(6), 951-3

Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients

Bryant A, Nivison-Smith I, Pillai ES, Kennedy G, Kalff A, Ritchie D, George B, Hertzberg M, Patil S, Spencer A, Fay K, Cannell P, Berkahn L, Doocey R, Spearing R, Moore J

(2014), Bone Marrow Transplant, 49(1), 17-23

Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol

Hocking J, Schwarer AP, Gasiorowski R, Patil S, Avery S, Gibson J, Iland H, Ho PJ, Joshua D, Muirhead J, Lai H, Irving I

(2014), Leuk Lymphoma, 55(12), 2801-7

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome

Tan P, Wei A, Mithraprabhu S, Cummings N, Liu HB, Perugini M, Reed K, Avery S, Patil S, Walker P, Mollee P, Grigg A, D'Andrea R, Dear A, Spencer A

(2014), Blood Cancer J, 4, e170

Causes and clinical significance of prolonged activated partial thromboplastin times in thalassaemia major

McFadyen J, Butler J, Malan E, Tran H

(2014), Ann Hematol, 93(5), 867-8

Prothrombin complex concentrate safely reverses warfarin-related bleeding

Tran H, Chunilal S

(2014), Evid Based Med, 19(2), 75

A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study)

Tran H, Brighton T, Grigg A, McRae S, Dixon J, Thurley D, Gandhi MK, Truman M, Marlton P, Catalano J

(2014), Br J Haematol, 167(2), 243-51

In-stent thrombosis following DDAVP administration: case report and review of the literature

Shah SN, Tran HA, Assal A, Ascunce RR, Yatskar L, Berger JS

(2014), Blood Coagul Fibrinolysis, 25(1), 81-3

370 371 372 373 374